Annual Accounts Payable
$167.30 K
NaN%
December 1, 2023
Summary
- As of February 9, 2025, CVKD annual accounts payable is $167.30 thousand
- During the last 3 years, CVKD annual accounts payable has fallen by -$237.60 thousand (-58.68%).
- CVKD annual accounts payable is now -58.68% below its all-time high of $404.90 thousand, reached on December 31, 2022.
Performance
CVKD Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$496.80 K
-$262.70 K-34.59%
September 1, 2024
Summary
- As of February 9, 2025, CVKD quarterly accounts payable is $496.80 thousand, with the most recent change of -$262.70 thousand (-34.59%) on September 1, 2024.
- Over the past year, CVKD quarterly accounts payable has stayed the same.
- CVKD quarterly accounts payable is now -34.59% below its all-time high of $759.50 thousand, reached on June 1, 2024.
Performance
CVKD Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CVKD Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -58.7% | 0.0% |
| 3 y3 years | -58.7% | +22.7% |
| 5 y5 years | -58.7% | +22.7% |
CVKD Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -58.7% | at low | -34.6% | +536.1% |
| 5 y | 5-year | -58.7% | at low | -34.6% | +536.1% |
| alltime | all time | -58.7% | at low | -34.6% | +536.1% |
Cadrenal Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $496.80 K(-34.6%) |
| Jun 2024 | - | $759.50 K(+89.7%) |
| Mar 2024 | - | $400.40 K(+139.3%) |
| Dec 2023 | $167.30 K | $167.30 K(+18.1%) |
| Sep 2023 | - | $141.70 K(+81.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $78.10 K(-34.7%) |
| Mar 2023 | - | $119.60 K(-70.5%) |
| Dec 2022 | $404.90 K | $404.90 K(+31.4%) |
| Sep 2022 | - | $308.20 K(+48.5%) |
| Jun 2022 | - | $207.50 K |
FAQ
- What is Cadrenal Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Cadrenal Therapeutics?
- What is Cadrenal Therapeutics annual accounts payable year-on-year change?
- What is Cadrenal Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Cadrenal Therapeutics?
- What is Cadrenal Therapeutics quarterly accounts payable year-on-year change?
What is Cadrenal Therapeutics annual accounts payable?
The current annual accounts payable of CVKD is $167.30 K
What is the all time high annual accounts payable for Cadrenal Therapeutics?
Cadrenal Therapeutics all-time high annual accounts payable is $404.90 K
What is Cadrenal Therapeutics annual accounts payable year-on-year change?
Over the past year, CVKD annual accounts payable has changed by -$237.60 K (-58.68%)
What is Cadrenal Therapeutics quarterly accounts payable?
The current quarterly accounts payable of CVKD is $496.80 K
What is the all time high quarterly accounts payable for Cadrenal Therapeutics?
Cadrenal Therapeutics all-time high quarterly accounts payable is $759.50 K
What is Cadrenal Therapeutics quarterly accounts payable year-on-year change?
Over the past year, CVKD quarterly accounts payable has changed by $0.00 (0.00%)